Fry JS - Search Results

1

2-Methoxy antimycin reveals a unique mechanism for Bcl-x(L) inhibition.

Schwartz PS, Manion MK, Emerson CB, Fry JS, Schulz CM, Sweet IR, Hockenbery DM. Schwartz PS, et al. Among authors: fry js. Mol Cancer Ther. 2007 Jul;6(7):2073-80. doi: 10.1158/1535-7163.MCT-06-0767. Mol Cancer Ther. 2007. PMID: 17620436

2

Small-molecule inhibitors of Bcl-2.

Manion MK, Fry J, Schwartz PS, Hockenbery DM. Manion MK, et al. Curr Opin Investig Drugs. 2006 Dec;7(12):1077-84. Curr Opin Investig Drugs. 2006. PMID: 17209525 Review.

3

Estimating the public health impact had tobacco-free nicotine pouches been introduced into the US in 2000.

Lee PN, Fry JS, Ljung T. Lee PN, et al. Among authors: fry js. BMC Public Health. 2022 May 21;22(1):1025. doi: 10.1186/s12889-022-13441-0. BMC Public Health. 2022. PMID: 35597944 Free PMC article.

4

Estimating the reduction in US mortality if cigarettes were largely replaced by e-cigarettes.

Lee PN, Fry JS, Gilliland S 3rd, Campbell P, Joyce AR. Lee PN, et al. Among authors: fry js. Arch Toxicol. 2022 Jan;96(1):167-176. doi: 10.1007/s00204-021-03180-3. Epub 2021 Oct 22. Arch Toxicol. 2022. PMID: 34677631 Free PMC article.

5

Investigating the effect of e-cigarette use on quitting smoking in adults aged 25 years or more using the PATH study.

Lee PN, Fry JS. Lee PN, et al. Among authors: fry js. F1000Res. 2020 Sep 7;9:1099. doi: 10.12688/f1000research.26167.3. eCollection 2020. F1000Res. 2020. PMID: 35813077 Free PMC article.

6

Further investigation of gateway effects using the PATH study.

Lee PN, Fry JS. Lee PN, et al. Among authors: fry js. F1000Res. 2020 Jun 15;9:607. doi: 10.12688/f1000research.24289.2. eCollection 2020. F1000Res. 2020. PMID: 35465062 Free PMC article.

7

Updating the evidence relating smoking bans to incidence of heart disease.

Lee PN, Fry JS, Thornton AJ. Lee PN, et al. Among authors: fry js. Regul Toxicol Pharmacol. 2019 Feb;101:172-186. doi: 10.1016/j.yrtph.2018.11.014. Epub 2018 Nov 27. Regul Toxicol Pharmacol. 2019. PMID: 30500390 Free article. Review.

8

Modeling the impact of changes in tobacco use on individual disease risks.

Djurdjevic S, Sponsiello-Wang Z, Lee PN, Fry JS, Weitkunat R, Lüdicke F, Baker G. Djurdjevic S, et al. Among authors: fry js. Regul Toxicol Pharmacol. 2018 Aug;97:88-97. doi: 10.1016/j.yrtph.2018.06.001. Epub 2018 Jun 9. Regul Toxicol Pharmacol. 2018. PMID: 29894733

9

Investigation into the risk of ultra-low tar cigarettes and lung cancer.

Lee PN, Fry JS, Hamling JS. Lee PN, et al. Among authors: fry js. Regul Toxicol Pharmacol. 2017 Oct;89:112-117. doi: 10.1016/j.yrtph.2017.07.023. Epub 2017 Jul 25. Regul Toxicol Pharmacol. 2017. PMID: 28751259 Free article.

10

Estimating the effect of differing assumptions on the population health impact of introducing a Reduced Risk Tobacco Product in the USA.

Lee PN, Fry JS, Hamling JF, Sponsiello-Wang Z, Baker G, Weitkunat R. Lee PN, et al. Among authors: fry js. Regul Toxicol Pharmacol. 2017 Aug;88:192-213. doi: 10.1016/j.yrtph.2017.06.009. Epub 2017 Jun 24. Regul Toxicol Pharmacol. 2017. PMID: 28651854 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters